A Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Etrolizumab as an induction and maintenance treatment for patients with moderately to severely active Crohn’s Disease

Project: Research

Project Details

Project Description

SERP Reference Number: HREC/14/SVHM/98.
SSA Reference Number: SSA/15/MonH/72.
Monash Health HREC Ref: 15307X
Effective start/end date15/04/1914/04/24


  • clinical trial
  • treatment efficacy
  • Crohn’s Disease